Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | Poly(I:C) | 2 | ug/mL | 1 | MMP-1 | 3584.0 | 27 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 1 | MMP-1 | 3236.0 | 29 | ||||
RA1869 | IKK16 | 2.0 | uM | 1 | MMP-1 | 3226.0 | 27 | ||||
N2759 | 5z-7-oxozeaenol | 0.6 | uM | 1 | MMP-1 | 1001.0 | 23 | ||||
N2759 | IKK16 | 2.0 | uM | 1 | MMP-1 | 554.0 | 39 | ||||
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 1 | MMP-1 | 6834.5 | 32 | ||||
RA1931 | IKK16 | 2.0 | uM | 1 | MMP-1 | 7103.0 | 42 | ||||
N2586 | 5z-7-oxozeaenol | 0.6 | uM | 1 | MMP-1 | 1351.5 | 30 | ||||
N2586 | IKK16 | 2.0 | uM | 1 | MMP-1 | 1716.0 | 45 | ||||
RA1869 | Tofacitinib | 0.3 | uM | 1 | MMP-1 | 5518.0 | 20 | ||||
RA1869 | 1 | MMP-1 | 4784.0 | 51 | |||||||
N2759 | Tofacitinib | 0.3 | uM | 1 | MMP-1 | 642.0 | 31 | ||||
N2759 | 1 | MMP-1 | 919.5 | 26 | |||||||
RA1931 | Tofacitinib | 0.3 | uM | 1 | MMP-1 | 7379.0 | 53 | ||||
RA1931 | 1 | MMP-1 | 8736.0 | 29 | |||||||
N2586 | Tofacitinib | 0.3 | uM | 1 | MMP-1 | 1068.0 | 21 | ||||
N2586 | 1 | MMP-1 | 2066.0 | 17 | |||||||
0 | MMP-1 | 17.0 | 54 | ||||||||
0 | MMP-1 | 17.0 | 41 | ||||||||
0 | MMP-1 | 20.0 | 47 | ||||||||
0 | MMP-1 | 27.5 | 66 | ||||||||
0 | MMP-1 | 29.0 | 37 | ||||||||
0 | MMP-1 | 28.0 | 60 | ||||||||
RA2159 | 2 | MMP-1 | 297.0 | 63 | |||||||
N2645 | 2 | MMP-1 | 108.0 | 55 |